219 related articles for article (PubMed ID: 8999814)
21. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
22. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes.
Tian N; Li X; Luo Y; Han Z; Li Z; Fan C
Mol Med Rep; 2014 Jan; 9(1):132-6. PubMed ID: 24173373
[TBL] [Abstract][Full Text] [Related]
23. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
[TBL] [Abstract][Full Text] [Related]
24. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
25. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
Lau PP; Zhu HJ; Nakamuta M; Chan L
J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
[TBL] [Abstract][Full Text] [Related]
26. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.
Kozarsky KF; Bonen DK; Giannoni F; Funahashi T; Wilson JM; Davidson NO
Hum Gene Ther; 1996 May; 7(8):943-57. PubMed ID: 8727508
[TBL] [Abstract][Full Text] [Related]
27. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
Yang Y; Sowden MP; Smith HC
J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
[TBL] [Abstract][Full Text] [Related]
28. Recapture of hepatic apolipoprotein B mRNA editing may be a promising strategy to relieve nephrotic dyslipidemia.
Hu P; Lu L; Hu B; Qin YH
Med Hypotheses; 2010 Dec; 75(6):561-3. PubMed ID: 20705399
[TBL] [Abstract][Full Text] [Related]
29. C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.
Fujino T; Navaratnam N; Jarmuz A; von Haeseler A; Scott J
Nucleic Acids Res; 1999 Jul; 27(13):2662-71. PubMed ID: 10373583
[TBL] [Abstract][Full Text] [Related]
30. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein B: from editosome to proteasome.
Chan L; Chang BH; Liao W; Oka K; Lau PP
Recent Prog Horm Res; 2000; 55():93-125; discussion 126. PubMed ID: 11036935
[TBL] [Abstract][Full Text] [Related]
32. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.
von Wronski MA; Hirano KI; Cagen LM; Wilcox HG; Raghow R; Thorngate FE; Heimberg M; Davidson NO; Elam MB
Metabolism; 1998 Jul; 47(7):869-73. PubMed ID: 9667237
[TBL] [Abstract][Full Text] [Related]
33. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Patterson AP
Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
[TBL] [Abstract][Full Text] [Related]
36. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
Davidson NO; Shelness GS
Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
38. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
Anant S; Davidson NO
Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
[TBL] [Abstract][Full Text] [Related]
39. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
[TBL] [Abstract][Full Text] [Related]
40. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
Srivastava RA
Biochem Biophys Res Commun; 1995 Jul; 212(2):381-7. PubMed ID: 7626051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
